Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
It is a closed-end fund that invests in healthcare and life sciences companies.
This is not a normal company that makes a product or sells a service. It is a closed-end fund, which means it is a pool of investor money that trades on the New York Stock Exchange like a stock. The fund's job is to take that money and buy shares of other companies in the healthcare and life sciences world. So when you buy a share, you are really buying a small slice of a big basket of drugmakers, biotech firms, medical device makers, and healthcare providers. The people who run it, a team at abrdn, get paid a management fee based on the fund's assets, and that fee is the main way the fund itself generates revenue. Think of it as a mutual fund with a twist: it trades all day on an exchange, so its price bounces around with supply and demand, not just the value of the stocks it holds.
The fund's portfolio is focused on what it calls life sciences, which is a fancy way of saying companies that discover drugs, make medical tools, or provide healthcare services. A big chunk of its holdings is in biotechnology and pharmaceuticals, with smaller slices in medical devices and healthcare providers. It does not try to mirror a boring index. Instead, the managers pick stocks they think will beat the market, so its returns can swing more than a plain healthcare index fund. That also means it can use a bit of borrowed money, called leverage, to try to boost gains, which adds risk when prices fall.
The fund has been around a long time, starting back in 1992 under a different name before abrdn took over the brand. It pays shareholders quarterly dividends, and the payout can include not just income from dividends of the stocks it holds but also capital gains from selling winners. If you are curious, the ticker and the fund's name are the same thing here. It is a niche product for people who want a professionally managed, concentrated bet on healthcare and biotech without picking individual stocks themselves.
Saved answer · last researched 11 Oct 2026